Skip to main content

8095 Innovation Park Drive, Fairfax, VA 22031



  • Lung cancer
  • Esophageal cancer
  • Mesothelioma
  • Large cell neuroendocrine carcinoma
  • Malignant pleural mesothelioma
  • Mediastinal diseases, tumors and masses
  • Neuroendocrine lung cancer
  • Non-small cell lung cancer
  • Mediastinal tumors
  • Chest wall tumors
  • Small cell lung cancer
  • Thymoma and thymic cancer
  • Pleural disease


Lung Cancer Screening Program Conditions and Treatments

Genomic Cancerous Tumor Assessment

The Inova Schar Cancer Institute participates in a genomic cancerous tumor assessment. A member of your care team will collect samples from tumor tissues which are analyzed under the microscope by a pathologist.

We systematically perform genetic testing on tumor samples to identify any changes in genes (mutations) than can be targeted with medication.

The Inova Molecular Tumor Board is a multidisciplinary team is composed of a Molecular Pathologist, Geneticist, and Medical Oncologists. The Board meets twice weekly to discuss genetic information obtained from tumor tissues to identify the best possible treatment.